Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Non-squamous Cell Non-Small Cell Lung Cancer × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7994 Neoplasms 5551 Prostatic Neoplasms 3760 Colorectal Neoplasms 3338 Lung Neoplasms 3038 Carcinoma, Non-Small-Cell Lung 2985 Pancreatic Neoplasms 2106 Carcinoma, Hepatocellular 2024 Leukemia, Myeloid, Acute 1891 Multiple Myeloma 1804 Stomach Neoplasms 1786 Neoplasm Metastasis 1607 Head and Neck Neoplasms 1567 Ovarian Neoplasms 1507 Brain Neoplasms 1463 Lymphoma 1454 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1447 Rectal Neoplasms 1412 Melanoma 1388 Colonic Neoplasms 1352 Leukemia 1271 Recurrence 1242 Uterine Cervical Neoplasms 1239 Glioblastoma 1116 Esophageal Neoplasms 1113 Lymphoma, Non-Hodgkin 1010 Leukemia, Lymphocytic, Chronic, B-Cell 932 Squamous Cell Carcinoma of Head and Neck 920 Urinary Bladder Neoplasms 917 Lymphoma, Follicular 880

Interventions

anlotinib 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03778138 2018-12-19

ALTER-L025

Henan Provincial People's Hospital

Phase 2 Unknown

Non-squamous Cell Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡